ロード中...
A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
Coronaviruses have caused several epidemics and pandemics including the ongoing coronavirus disease 2019 (COVID-19). Some prophylactic vaccines and therapeutic antibodies have already showed striking effectiveness against COVID-19. Nevertheless, concerns remain about antigenic drift in SARS-CoV-2 as...
保存先:
| 出版年: | bioRxiv |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Cold Spring Harbor Laboratory
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7885913/ https://ncbi.nlm.nih.gov/pubmed/33594361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.02.11.430866 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|